Skip to main content
Caplight Logo









EBAMed SA

EBAMed SA

Private
GenevaHealthcare & Life Scienceshttps://eba-med.com/

Last Round

Series A

Extension

Jan 27, 2025

Total Funding Raised

$41.06M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

EBAMed SA is a medical devices company that develops innovative solutions for the non-invasive treatment of heart arrhythmias using external beam ablation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

proton therapycardiac radioablationmedical devicebeam synchronizationmotion trackingventricular tachycardianon-invasive surgerymedical imagingcardiac arrhythmiaAI medical deviceimage-guided therapyradiation oncologymedtechAI-driven surgerydigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EBAMed SA Comparables

Compare EBAMed SA with similar companies based on industry and business-model similarity.

EBAMed SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Siemens Healthineers
71%
Ion Beam Applications
64%
GE HealthCare Technologies Inc.
64%

EBAMed SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJan 27, 2025
Series AJan 24, 2024
Series AJun 27, 2023
SeedSep 28, 2022
GrantSep 23, 2020
Seed
Aug 21, 2019

Key People

Founding team and executive leadership

Marina Izzo

Chief Executive Officer

Executive Team

Adriano Garonna

Chief Technology Officer

Executive Team

EBAMed SA Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 103% MoM, reaching 1.3K.

  • Jul 17, 2026

    Grew 20% QoQ, from 15 to 18 employees.

EBAMed SA Filings

Explore SEC and related filing metadata, where available.

EBAMed SA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EBAMed SA's valuation, stock price, and market status.

Is EBAMed SA a public or private company?

EBAMed SA is a private company.

What is the current stock price of EBAMed SA?

EBAMed SA is a private company with no public stock price. No recent secondary market data is available.

How much is EBAMed SA worth (valuation)?

Valuation information for EBAMed SA is not publicly available.

Can I buy EBAMed SA stock?

EBAMed SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EBAMed SA's last funding round?

EBAMed SA's most recent funding round was Series A Extension on January 27, 2025.

Who are the main investors in EBAMed SA?

Key investors in EBAMed SA include Panakès Partners.

Will EBAMed SA IPO soon?

No public IPO plans have been announced for EBAMed SA.

How can I track EBAMed SA secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EBAMed SA's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGeneva
Employee Range14
Year Founded2018
Last FundingJan 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?